Background Previous studies have shown the feasibility of peripheral arterial ultrasound angioplasty.
Methods and Results In this report, we describe the use of percutaneous therapeutic ultrasound for coronary angioplasty. In vitro, 11 postmortem, atherosclerotically occluded coronary arteries were obtained to assess catheter-delivered ultrasound for arterial recanalization as well as for assessment of the size of particulate debris. Clinically, coronary ultrasound angioplasty was performed in 19 patients (mean age, 56 years) to assess safety and feasibility for the treatment of obstructive coronary atherosclerosis. Three patients with unstable angina and 16 with exercise-induced myocardial ischemia were treated with a prototype 4.6F coronary catheter ultrasound ablation device with a 1.7-mm diameter ball tip. The ultrasound coronary catheter delivered ultrasound energy at 19.5 kHz, with a power output of 16 to 20 W at the transducer.
Energy is delivered in a pulsed mode with a 50% duty cycle of 30 milliseconds. Patients were treated for a mean of 493 C atheter-delivered high-intensity, low-frequency ultrasound energy has been shown experimentally to recanalize guide wire-resistant fibrous and calcific atherosclerotic occlusions,1-4 to rapidly dissolve arterial thrombi,35 and to induce vasodilation in vitro and in vivo. 6 The microscopic particulate debris generated during plaque ablation and thrombus dissolution are small and comparable to the particulates from other clinically used modalities. 13, 5 Clinical studies in humans have demonstrated that this technique can be used safely and effectively for peripheral angioplasty.7-10 Studies using a recently developed coronary ultrasound probe system have shown that this device can be used to dissolve thrombotic canine coronary occlusions, that the delivered ultrasound energy results in coronary vasodilation, and that there is no ultrasound-induced arterial damage." This report describes the initial clinical studies performed to assess if percutaneous catheter-delivered high-intensity, low-frequency ultrasound is safe seconds (range, 130 to 890) with intracoronary ultrasound ablation. All lesions were treated with adjunctive balloon angioplasty. All 11 postmortem coronary occlusions were recanalized, and 99% of the particulates generated were < 10 ,um in diameter. We found that after ultrasound, mean (±SD) coronary arterial stenosis fell from 80±12% to 60±18% (P<.001) and to 26±11% (P<.001) after adjunctive balloon angioplasty. Mean pressures required to achieve full balloon inflation were 2.7 atm (range, 1 to 5.5) with a median of 3.0-mm balloon size (2.5 to 3.5). No ultrasound-related complications were identified.
Conclusions Intracoronary ultrasound plaque ablation appears to be safe. Our findings suggest that catheter-delivered high-intensity, low-frequency ultrasound may be useful for lesion debulking and enhancing arterial distensibility, allowing balloon dilation at relatively low pressures. 
Clinical Findings
Ultrasound angioplasty in patients reduced the stenosis in 17 of 19 coronary lesions treated. Fig 3 shows the reduction in the stenosis of the left anterior descending coronary artery of case 7. As measured by quantitative digital angiography, the percent stenosis was reduced from 71 to 57 after ultrasound angioplasty and to 43 after adjunctive balloon angioplasty. The mean percent reduction in stenosis for the group was from 80+12 to 60±18 (P<.0001), and the mean (±SD) minimum lumen diameter (MLD) increased from 0.6± 0.3 mm to 1.1±0.5 mm (P<.001) after application of catheter-delivered ultrasound energy. Angiographically, the residual luminal contours were all smooth in appearance, with no clefts or haziness visible, and the arterial run-off was brisk.
In a single case (patient 3), there was a guiding catheter-induced dissection of a right coronary artery after use of the ultrasound catheter. Balloon dilatation failed in this case to restore arterial patency, but there were no clinical sequelae. All the other 18 patients underwent successful adjunctive balloon angioplasty, the final mean residual stenosis being 26±+ 11% (P<.001), and the MLD increased to 2.4±0.5 mm (P<.001).
Specific attention was given to assess potential complications. There was no evidence of ultrasound-induced emboli, heart block, arterial dissection, perforation, vasospasm, or abrupt closure. There was no pain or significant ECG changes associated with the intracoronary delivery of ultrasound energy. While ultrasound was not seen to induce arterial vasodilation for the patients as a group, there was one case in which ultrasound reversed vasospasm that was refractory to 700 ,gg of intracoronary nitroglycerin.
Pressures required to achieve full balloon inflation, ie, at which the stenosis yielded, were 2.7 atm (range, 1.0 to 5.5), with a median of 3.0-mrnm balloon size (2.5 to 3.5). During the next 24 hours, all patients were asymptomatic, and there was no ECG evidence or enzymatic evidence of myocardial infarction in any patient. Angiographic follow-up at 18 to 24 hours demonstrated continued patency of all except one vessel (see Table) . In the one patient with a previously totally occluded left anterior descending coronary artery, the artery silently reoccluded; patency was restored by repeat balloon angioplasty. For the other 17 patients, the mean MLD of 2.4 mm did not change 24 hours after angioplasty, but the arterial stenosis increased from 26±+-11% to 32±11% in the same period (P<.02). Administration of intracoronary nitroglycerin resulted in no significant overall increase in lumen diameter at any stage of the procedure or at 24 hours.
Discussion
This is the first clinical report on the use of catheterdelivered high-intensity, low-frequency ultrasound for the treatment of coronary arterial obstructions. For the patient group, mean stenosis fell by 20% and the MLD increased by 0.5 mm (P<.001). In 16 of 19 lesions treated by ultrasound, there was a fall in percent stenosis by >20% and/or an increase in MLD by 0.3 mm. This preliminary study showed that the procedure was safe despite prolonged exposure to ultrasound energy of up to 15 minutes (138 to 890 seconds). There was no evidence of arterial emboli, heart block, arterial perforation, dissection, or vasospasm, nor was there evidence of myocardial ischemia or infarction.
The in vitro data, using the same coronary ultrasound angioplasty system as used clinically, demonstrate the effectiveness of ultrasound energy for arterial recanalization: Namely, the unactivated probe in the in vitro studies was not able to cross the calcific coronary arterial occlusions. Subsequent activation of ultrasound energy resulted in probe passage and the generation of a smooth circular arterial lumen conforming to the shape of the ultrasound probe tip. These findings are consistent with previous studies1-5,7-11 and suppcfrt the mechanistic role of ultrasound energy for the improvement of the arterial lumen diameter in clinical cases undergoing coronary ultrasound angioplasty.
During adjunctive balloon angioplasty after ultrasound exposure, it was noted that the mean balloon pressures to achieve full inflation, ie, the yield pressure of the underlying lesion, were relatively low at 2.7 atm (range, 1 to 5.5). These findings are consistent with our initial clinical observations in treating peripheral arteries: Namely, that after ultrasound application, there was only a slight "waist" or deformation of the inflated balloon, suggesting that the resistance of the lesions to pressure had been decreased.7 We subsequently found in vitro that after 2 these findings may simply reflect the inherent recoil that may occur after a balloon angioplasty procedure.16
A current limitation of the coronary ultrasound ablation device is that the size of the lumen generated is restricted by the probe tip size. Approaches to achieve larger lumen size include the use of larger probe tips as well as increasing the ultrasound power output to augment plaque ablation.
At present, there are a number of interventional devices being tested in the coronary circulation to improve the results of balloon angioplasty.17-20 Ultrasound appears particularly promising because, as we predicted from previous experiments and clinical experience in peripheral arteries,10 no adverse reaction to prolonged ultrasound exposure occurred; also, ultrasound is potentially useful by enhancing arterial distensibility and possibly modifying the atherosclerotic plaque itself. The clinical usefulness of another known property of ultrasound, ie, thrombus dissolution,3-512 remains to be determined by further experience in patients with acute coronary syndromes.
